Article info

Original research
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization

Authors

  • Alycia Gardner Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USACancer Biology PhD Program, University of South Florida, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Álvaro de Mingo Pulido Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Kay Hänggi Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Sarah Bazargan Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USACancer Biology PhD Program, University of South Florida, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Alexis Onimus Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USAMolecular Medicine PhD Program, University of South Florida, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Agnieszka Kasprzak Analytic Microscopy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Jose R Conejo-Garcia Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Katarzyna A Rejniak Department of Integrated Mathematical Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA PubMed articlesGoogle scholar articles
  • Brian Ruffell Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USADepartment of Breast Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA PubMed articlesGoogle scholar articles

Citation

Gardner A, de Mingo Pulido Á, Hänggi K, et al
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.